ITGA2B and autoimmune thrombocytopenic purpura: A total of 148 ITP patients were included to determine the antiplatelet autoantibodies against GPIIb/IIIa and GPIb/IX, including 69 patients for positive autoantibodies and 79 for negative autoantibodies.